# Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PKs) of ZYDPLA1 Following Oral Administration in Healthy Volunteers

> **NCT02620592** · PHASE1 · COMPLETED · sponsor: **Zydus Lifesciences Limited** · enrollment: 84 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** ZYDPLA1 tablet
- **DRUG:** Placebo tablet

## Key facts

- **NCT ID:** NCT02620592
- **Lead sponsor:** Zydus Lifesciences Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2015-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02620592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02620592, "Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PKs) of ZYDPLA1 Following Oral Administration in Healthy Volunteers". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02620592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*